Activity of GDC-0941, an inhibitor of phosphoinositol 3 kinase (PI3K), in gastrointestinal stromal tumor (GIST) xenograft and duration of response after discontinuation of treatment in combination with imatinib.

American Society of Clinical Oncology, Journal of Clinical Oncology, 15_suppl(28), p. 10020-10020

Journal article published in 2010 by G. Floris, R. Sciot, A. Wozniak, C. Deroose

, P. Vermaelen, B. Dewaele, M. Debiec-Rychter, P. Schoffski

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by